MedPath

苏州第壹制药有限公司

Ownership
-
Established
2005-12-23
Employees
-
Market Cap
-
Website
www.ntpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

176

NMPA:176

Drug Approvals

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20253592
Approval Date
Mar 11, 2025
NMPA

Chlorotrianisene

Product Name
氯烯雌醚
Approval Number
国药准字H32023099
Approval Date
Jun 4, 2024
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083932
Approval Date
Jun 13, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083933
Approval Date
Jun 13, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083931
Approval Date
Jun 13, 2023
NMPA

Omeprazole Sodium for Injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20066218
Approval Date
Jul 5, 2021
NMPA

Pefloxacin Mesylate for Injection

Product Name
注射用甲磺酸培氟沙星
Approval Number
国药准字H20064859
Approval Date
Mar 25, 2021
NMPA

Amlodipine Maleate Tablets

Product Name
马来酸氨氯地平片
Approval Number
国药准字H20113392
Approval Date
Mar 25, 2021
NMPA

Cytidine Disodium Triphosphate for Injection

Product Name
注射用三磷酸胞苷二钠
Approval Number
国药准字H20067604
Approval Date
Mar 25, 2021
NMPA

Methylphenidate Hydrochloride for Injection

Product Name
注射用盐酸哌甲酯
Approval Number
国药准字H32026313
Approval Date
Sep 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.